|
|
|
|
|
|
|
|
|
|
Course Criteria
Add courses to your favorites to save, share, and find your best transfer school.
-
2.00 Credits
A case-based discussion section that allows students to integrate the knowledge presented in RXPS 612 and in RXTH 674 and RXTH 683 by evaluation of pertinent case studies. Student devises a rational therapeutic plan and determines appropriate monitoring parameters for safety and efficacy. Identifies and addresses patient-education issues surrounding disease and drug therapy Prerequisite: Completion of all P1 and AQ P2 courses. Corequisite: RXPS 612, RXTH 674, RXTH 683.
-
2.00 Credits
A case-based discussion section that allows students to integrate the knowledge presented in RXTH 684 and in RXPS 613 by evaluation of pertinent case studies. Student devises a rational therapeutic plan and determines appropriate monitoring parameters for safety and efficacy. Identifies and addresses patient-education issues surrounding disease and drug therapy. Prerequisite: P2 SQ standing. Corequisite: RXPS 613, RXTH 684.
-
4.00 Credits
Focuses on current and/or controversial topics in the area of cardiology and cardiovascular pharmacotherapy. More detailed focus on the evidence behind some cardiovascular guidelines.
-
2.00 Credits
Exposure to and participation in clinical research in internal medicine clinical pharmacy practice.
-
3.50 Credits
Part of an eleven-course sequence. Introduces students to the pharmacology, pharmacokinetics, and pharmacodynamics of antiinfectives; as well as management (evaluation, treatment, monitoring and follow-up) of patients with neurological diseases. Students integrate knowledge, attitudes and skills in a variety of ways to accomplish course outcomes. Includes anatomy, physiology, pharmacology, pharmacokinetics, pharmacotherapy and clinical-trial evidence as they relate to antiinfectives. Enables students to integrate their knowledge of the disciplines in the context of formulating individualized pharmacotherapeutic plans. Prerequisite: P3, AQ standing.
-
4.50 Credits
Part of a twelve-course sequence. Introduces students to the pharmacology, pharmacokinetics, and pharmacodynamics of agents used in the treatment of endocrine and GI dysfunction; as well as management (evaluation, treatment, monitoring, and follow-up) of patients with endocrine and GI dysfunctions. Students integrate knowledge, attitudes, and skills in a variety of ways to accomplish course outcomes. Includes pathophysiology, pharmacology, pharmacokinetics, pharmacotherapy, and clinical-trial evidence as they relate to endocrine and GI drugs. Enables students to integrate their knowledge of the disciplines studied in the context of formulating an individualized pharmacotherapeutic plan for a given patient.
-
4.50 Credits
Part of a twelve-course sequence. Introduces students to the pharmacology, pharmacokinetics, and pharmacodynamics of agents used in the treatment of endocrine and GI dysfunction; as well as management (evaluation, treatment, monitoring, and follow-up) of patients with endocrine and GI dysfunctions. Students integrate knowledge, attitudes, and skills in a variety of ways to accomplish course outcomes. Includes pathophysiology, pharmacology, pharmacokinetics, pharmacotherapy, and clinical-trial evidence as they relate to endocrine and GI drugs. Enables students to integrate their knowledge of the disciplines studied in the context of formulating an individualized pharmacotherapeutic plan for a given patient.
-
4.50 Credits
Part of an eleven-course sequence. Introduces students to the pharmacology, pharmacokinetics, and pharmacodynamics of agents used in the treatment of psychiatric disease and addictions; as well as management (evaluation, treatment, monitoring and follow-up) of patients with these conditions. Students integrate knowledge, attitudes, and skills in a variety of ways to accomplish the course outcomes. Presents pathophysiology, pharmacology, pharmacokinetics, pharmacotherapy and clinical-trial evidence as they relate to the drugs used for these miscellaneous conditions. Enables students to integrate their knowledge of the disciplines in the context of formulating an individualized pharmacotherapeutic plan for a given patient. Prerequisite: P3, AQ standing.
-
3.50 Credits
Part of a twelve-course sequence. Introduces students to the pharmacology, pharmacokinetics and pharmacodynamics of agents used in the treatment of various conditions--including arthritis, gout, glaucoma, dermal conditions, incontinence, SLE, MS, BPH, and others; as well as management (evaluation, treatment, monitoring and follow-up) of patients with these conditions. Students integrate knowledge, attitudes and skills in a variety of ways to accomplish the course outcomes. Includes pathophysiology, pharmacology, pharmacokinetics, pharmacotherapy, and clinical trial evidence as they relate to the drugs used for the conditions indicated. Enables students to integrate their knowledge of the disciplines studied in the context of formulating an individualized pharmacotherapeutic plan for a given patient. Prerequisite: P3 SQ standing.
-
2.50 Credits
Part of a twelve-course sequence. Introduces students to the pharmacology, pharmacokinetics, and pharmacodynamics of oncology agents and agents used in the treatment of transplant recipients; as well as management (evaluation, treatment, monitoring, and follow-up) of patients with these conditions. Students integrate knowledge, attitudes, and skills in a variety of ways to accomplish course outcomes. Includes pathophysiology, pharmacology, pharmacokinetics, pharmacotherapy, and clinical-trial evidence as they relate to the drugs used to treat the conditions indicated. Enables students to integrate their knowledge of the disciplines studied in the context of formulating an individualized pharmacotherapeutic plan for a given patient. Prerequisite: P3 SQ standing.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Privacy Statement
|
Terms of Use
|
Institutional Membership Information
|
About AcademyOne
Copyright 2006 - 2024 AcademyOne, Inc.
|
|
|